Viscosupplementation Market Business Opportunities by 2027 - Bioventus, Anika Therapeutics, Seikagaku, Zimmer Biomet, Ferring, Lifecore Biomedical, Salix Pharmaceuticals, Fidia Farmaceutici, and LG Life Sciences

Viscosupplementation market is anticipated to grow in the forecast period owing to driving factors such as rising number of increasing geriatric population, increasing demand for minimally invasive surgical procedures, high patient awareness about new drugs. Moreover and devices for the treatment of osteoarthritis and rising obese population globally, rising investments by major players for the growing demand are also offering opportunities in the market growth during the forecast period.

The global viscosupplementation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading viscosupplementation market players and offers key trends and opportunities in the market.

Get PDF sample copy of this Study: https://www.theinsightpartners.com/sample/TIPRE00006722/?opr-ss

Viscosupplementation is a method in which a thick fluid called hyaluronate is injected into the knee joint. There are no remedies for osteoarthritis, so viscosupplementation will not counteract osteoarthritis of the knee. However, it is claimed that hyaluronate helps in improving the lubricating properties of the synovial fluid, lessen the pain from osteoarthritis of the knee, improves mobility, and provide a higher and more convenient level of activity. Viscosupplementation is a minimally invasive procedure which involves injection of gel-like substance. Currently hyaluronate injections are only approved viscosupplementation therapy of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues.

The List of Companies

1. Bioventus Inc.
2. Anika Therapeutics
3. Seikagaku Corporation
4. Zimmer Biomet
5. Smith & Nephew PLC
6. Ferring B.V.
7. Lifecore Biomedical, LLC (Landec)
8. Salix Pharmaceuticals
9. Fidia Farmaceutici S.P.A
10. LG Life Sciences Ltd.

The report analyzes factors affecting viscosupplementation market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the viscosupplementation market in these regions.

Buy the complete report with Comprehensive table of contents @ https://www.theinsightpartners.com/sample/TIPRE00006722/

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global viscosupplementation market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The viscosupplementation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.